PACT Pharma establishes safety of CRISPR T cell receptor therapy
15 Nov 2022 //
FIERCEBIOTECH
PACT Pharma to Present Data Highlighting 1st-of-itsKind Personalized Neoantigen
02 Nov 2022 //
PRNEWSWIRE
PACT Pharma Announces Agreement to Sell Select Assets to AmplifyBio
03 Oct 2022 //
BIOSPACE
PACT unveils venture tied to diversion of some 50 staffers
03 Oct 2022 //
FIERCEBIOTECH
PACT to cull lead asset, divert 54 employees to new business development venture
25 Aug 2022 //
FIERCEBIOTECH
PACT Pharma lets go of nearly 100 staffers
18 Jul 2022 //
FIERCEBIOTECH